CIK 0000318306
- Non-accelerated filer
- Smaller reporting company
ABEONA THERAPEUTICS INC.
Sign in to watch- Ticker
- ABEO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 830221517
- Phone
- +1 646-813-4701
- Business address
- 6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
- Former names
- PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $34,349
- in 1 filing
- Open-market sales, last 90 days
- $296,397
- in 5 filings
Net −$262,048. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-10-08 | CARR EDWARD Chief Financial Officer | Sale | −29,122 | $1.05 | $31K | 400,169 |
| 2021-08-10 | CARR EDWARD Chief Financial Officer | Grant or award | +238,000 | 429,291 | ||
| 2021-08-10 | CARR EDWARD Chief Financial Officer | Grant or award · Stock Option (right to buy) | +476,000 | 476,000 | ||
| 2021-04-05 | CARR EDWARD Chief Accounting Officer | Sale | −35,000 | $1.80 | $63K | 191,291 |
| 2021-04-01 | CARR EDWARD Chief Accounting Officer | Sale | −20,445 | $1.85 | $38K | 226,291 |
| 2021-03-01 | CARR EDWARD Chief Accounting Officer | Grant or award | +50,000 | 246,736 | ||
| 2021-03-01 | CARR EDWARD Chief Accounting Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2020-11-20 | CARR EDWARD Chief Accounting Officer | Grant or award · Stock Option (right to buy) | +28,919 | 28,919 | ||
| 2020-11-20 | CARR EDWARD Chief Accounting Officer | Returned to the company · Stock Option (right to buy) | −28,919 | 0 | ||
| 2020-11-20 | CARR EDWARD Chief Accounting Officer | Grant or award · Stock Option (right to buy) | +51,081 | 51,081 | ||
| 2020-11-20 | CARR EDWARD Chief Accounting Officer | Returned to the company · Stock Option (right to buy) | −51,081 | 0 | ||
| 2020-11-20 | CARR EDWARD Chief Accounting Officer | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2020-11-20 | CARR EDWARD Chief Accounting Officer | Returned to the company · Stock Option (right to buy) | −10,000 | 0 | ||
| 2020-11-20 | CARR EDWARD Chief Accounting Officer | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2020-11-20 | CARR EDWARD Chief Accounting Officer | Returned to the company · Stock Option (right to buy) | −35,000 | 0 | ||
| 2020-10-09 | CARR EDWARD Chief Accounting Officer | Grant or award | +143,182 | 196,736 | ||
| 2020-05-20 | CARR EDWARD Chief Accounting Officer | Grant or award | +40,000 | 53,554 | ||
| 2020-05-20 | CARR EDWARD Chief Accounting Officer | Grant or award · Employee Stock Option (right to buy) | +28,919 | 28,919 | ||
| 2020-03-19 | CARR EDWARD Chief Accounting Officer | Sale | −6,446 | $1.81 | $12K | 13,554 |
| 2020-03-16 | CARR EDWARD Chief Accounting Officer | Grant or award · Employee Stock Option (right to buy) | +51,081 | 51,081 |
Page 1 of 2 · 23 trades